Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Skin Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07715136
What this trial is testing

BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy

Who this might be right for
Inflammatory Myopathy
iCell Gene Therapeutics 10
Not applicableStudy completedNCT01551667
What this trial is testing

Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds

Who this might be right for
Diabetic FootFoot UlcerLeg Ulcer+2 more
Centre Hospitalier Universitaire de Nīmes 69
Not applicableActive Not RecruitingNCT06598137
What this trial is testing

Study to Examine Lesions of the Skin Using Confocal Laser Microscopy

Who this might be right for
Benign Skin TumorBasal Cell CarcinomaMelanoma+1 more
LMU Klinikum 645
Testing effectiveness (Phase 2)Ended earlyNCT01571895
What this trial is testing

Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
Dompé Farmaceutici S.p.A 4
Not applicableActive Not RecruitingNCT06513507
What this trial is testing

A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.

Who this might be right for
Rheumatoid ArthritisInflammatory Disease
Raphael Pharma 12
Not applicableUnknownNCT04499001
What this trial is testing

Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs

Who this might be right for
Arthritis, RheumatoidSpondyloarthritisBiological Therapy
Hôpital Cochin 60
Testing effectiveness (Phase 2)Study completedNCT02998671
What this trial is testing

Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne

Who this might be right for
Acne Vulgaris
Novartis Pharmaceuticals 52
Large-scale testing (Phase 3)Active Not RecruitingNCT05832034
What this trial is testing

Add-on Intravenous Immunoglobulins in Early Myositis

Who this might be right for
Inflammatory Myopathy, IdiopathicDermatomyositisAntisynthetase Syndrome+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 44
Testing effectiveness (Phase 2)Ended earlyNCT02975336
What this trial is testing

A Phase II Study of M2951 in SLE

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 469
Testing effectiveness (Phase 2)Looking for participantsNCT06699121
What this trial is testing

Assess the Safety and Efficacy of LB-P8 in Patients With PSC

Who this might be right for
Primary Sclerosing Cholangitis (PSC)
LISCure Biosciences 87
Post-approval studies (Phase 4)Study completedNCT02798211
What this trial is testing

Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 258
Not applicableStudy completedNCT05703802
What this trial is testing

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Who this might be right for
SepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more
University Hospital Muenster 30
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Post-approval studies (Phase 4)Looking for participantsNCT06499233
What this trial is testing

Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease

Who this might be right for
Pneumonia, PneumocystisAutoimmune Inflammatory Rheumatic DiseaseAutoimmune Diseases+2 more
Tongji Hospital 800
Not applicableStudy completedNCT05098678
What this trial is testing

Zinc Supplementation and Behçet's Syndrome

Who this might be right for
Behcet Syndrome
Tabriz University of Medical Sciences 50
Large-scale testing (Phase 3)Study completedNCT00984815
What this trial is testing

Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment

Who this might be right for
OsteoarthritisRheumatoid ArthritisChronic Low Back Pain+2 more
Amgen 86
Not applicableUnknownNCT04848649
What this trial is testing

Shortening Treatments Of Chronic Inflammatory Conditions

Who this might be right for
PsoriasisInflammatory Bowel Diseases
Centre Hospitalier Universitaire de Besancon 60
Large-scale testing (Phase 3)Ended earlyNCT01275976
What this trial is testing

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

Who this might be right for
TraumaInflammationSepsis+1 more
UMC Utrecht 11
Early research (Phase 1)Looking for participantsNCT06564389
What this trial is testing

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Who this might be right for
Healthy ParticipantsAtopic Dermatitis
Pfizer 119
Not applicableNot Yet RecruitingNCT07770399
What this trial is testing

Biological Profile of Primary and Secondary Lymphedema: Inflammatory, Endothelial, Metabolic, Lymphatic, and Fibrotic Markers

Who this might be right for
Primary LymphedemaSecondary Lymphedema
University Medical Centre Ljubljana 90
Next Page